Enova Executive Chairman receives 8,979 stock options
Enova International Executive Chairman David Fisher received a grant of 8,979 non-qualified stock options with a limited stock appreciation right (SAR) on May 13, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Enova International Executive Chairman David Fisher received a grant of 8,979 non-qualified stock options with a limited stock appreciation right (SAR) on May 13, 2026. The options have an exercise price of $166.88 per share and expire on May 13, 2033.
The award vests in three substantially equal annual installments on May 13 of 2027, 2028 and 2029, contingent on continued employment. The tandem SAR can only be exercised following a defined change in control and is payable only if a qualifying offer for Enova is made.
Insider Trade Summary
Grant/Award: 8,979 shares
Grant/Award
1 txn
Insider
Fisher David
Role
Executive Chairman
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Non-Qualified Stock Option (right to buy) with limited SAR | 8,979 | $0.00 | $0.00 |
Holdings After Transaction:
Non-Qualified Stock Option (right to buy) with limited SAR — 8,979 contracts (Direct)
Footnotes (3)
- F1. The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made.
- F2. The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer.
- F3. The options shall vest in substantially equal one-third increments on each of the following dates as long as grantee serves as an employee of Issuer or an affiliate thereof through the applicable vesting date: May 13, 2027, May 13, 2028 and May 13, 2029.
Key Figures
Options granted: 8,979 options
Exercise price: $166.88 per share
Expiration date: May 13, 2033
+5 more
8 metrics
Options granted
8,979 options
Non-qualified stock option grant on May 13, 2026
Exercise price
$166.88 per share
Strike price for granted options
Expiration date
May 13, 2033
Option and SAR expiration
Underlying shares
8,979 shares
Enova common stock underlying the options
Vesting schedule start
May 13, 2027
First one-third vesting date
Second vesting date
May 13, 2028
Second one-third vesting date
Final vesting date
May 13, 2029
Final one-third vesting date
Shares after transaction
8,979 derivative securities
Total options held after this grant
Key Terms
Non-Qualified Stock Option, stock appreciation right, Change in Control, Offer Value Per Share, +1 more
5 terms
Non-Qualified Stock Option financial
"Non-Qualified Stock Option (right to buy) with limited SAR"
A non-qualified stock option (NSO) is a contract that lets an employee or service provider buy company shares at a fixed price for a set period, like a voucher to purchase stock later at today’s price. It matters to investors because exercising NSOs creates ordinary income for the holder and can increase share count, affecting a company’s earnings and ownership mix; think of it as a future sale that can dilute existing shareholders and has immediate tax consequences for the recipient.
stock appreciation right financial
"The limited stock appreciation right ("SAR") and employee stock option were granted in tandem."
A stock appreciation right (SAR) is a form of employee pay that gives the holder the right to receive the increase in a company's share price over a set reference price, paid in cash or shares, without having to buy stock first. It matters to investors because SARs can create future cash outflows or dilute existing shareholders if settled in stock, and they align employee incentives with share-price performance like a bonus tied to a home's price rise.
Change in Control financial
"only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs"
A "change in control" occurs when the ownership or management of a company shifts significantly, such as through a merger, acquisition, or sale of a large part of its assets. This change can impact how the company is run and may influence its future direction. For investors, it matters because it can affect the company's stability, strategy, and value, often signaling potential changes in investment risk or opportunity.
tender offer financial
""Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power"
A tender offer is a proposal made by a person or company to buy shares from existing shareholders at a set price, usually higher than the current market value, within a specific time frame. It matters to investors because it can lead to a change in ownership or control of a company, and shareholders must decide whether to sell their shares at the offered price.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Enova (ENVA) Executive Chairman David Fisher report in this Form 4?
David Fisher reported receiving 8,979 non-qualified stock options with a limited stock appreciation right. The grant is compensation-based, carries a $166.88 exercise price, and expires in 2033, with vesting spread over three annual installments starting in 2027.
How many Enova (ENVA) options were granted to David Fisher and at what price?
David Fisher was granted 8,979 non-qualified stock options linked to Enova common stock. The options have an exercise price of $166.88 per share, meaning he can buy shares at that price once the options vest and are exercised within the stated term.
When do David Fisher’s Enova (ENVA) stock options vest and expire?
The options vest in three substantially equal one-third installments on May 13, 2027, May 13, 2028 and May 13, 2029. They expire on May 13, 2033, giving Fisher several years after full vesting to exercise them, subject to plan terms.
What is the limited stock appreciation right (SAR) tied to David Fisher’s Enova (ENVA) options?
The SAR is granted in tandem with the stock option, so exercising one cancels the other. It is exercisable only after a defined change in control and pays based on the excess of an offer value per share over the option exercise price, if a qualifying offer occurs.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates